“Periplocin improves the sensitivity of oxaliplatin-resistant hepatocellular carcinoma cells by inhibiting M2 macrophage polarization” (2025) Biomolecules and Biomedicine, 25(4), pp. 857–868. doi:10.17305/bb.2024.10928.